Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Archiv der Pharmazie, 357, 9, S. 2400267-
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2024
- Event
-
Veröffentlichung
- (where)
-
Weinheim
- (who)
-
Wiley
- (when)
-
2024
- Creator
-
Haupenthal, Jörg
Rafehi, Muhammad
Kany, Andreas M.
Lespine, Anne
Stefan, Katja
Hirsch, Anna K. H.
Schmitt, Sven Marcel
- DOI
-
10.1002/ardp.202400267
- URN
-
urn:nbn:de:bvb:384-opus4-1161369
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Haupenthal, Jörg
- Rafehi, Muhammad
- Kany, Andreas M.
- Lespine, Anne
- Stefan, Katja
- Hirsch, Anna K. H.
- Schmitt, Sven Marcel
- Universität Augsburg
- Wiley
Time of origin
- 2024
Other Objects (12)
Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs)
Membrane‐Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram‐Negative Superbugs
A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics
Repurposing of antibiotics for clinical management of COVID-19: a narrative review
Glutamate transporter: an unexpected target for some antibiotics
Antibiotics inhibiting bacterial protein synthesis, and novel resistance mechanisms
Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects
Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression
Drug repurposing
Quantifying Dynamic Phenotypic Heterogeneity in Resistant Escherichia coli under Translation‐Inhibiting Antibiotics
Drug repurposing in cardiology
Drug Repurposing in Oncology
Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs)
Membrane‐Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram‐Negative Superbugs
A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics
Repurposing of antibiotics for clinical management of COVID-19: a narrative review
Glutamate transporter: an unexpected target for some antibiotics
Antibiotics inhibiting bacterial protein synthesis, and novel resistance mechanisms
Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects
Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression
Drug repurposing
Quantifying Dynamic Phenotypic Heterogeneity in Resistant Escherichia coli under Translation‐Inhibiting Antibiotics
Drug repurposing in cardiology
Drug Repurposing in Oncology
Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy‐coupling factor transporters (ECFTs)
Membrane‐Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram‐Negative Superbugs
A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics
Repurposing of antibiotics for clinical management of COVID-19: a narrative review
Glutamate transporter: an unexpected target for some antibiotics
Antibiotics inhibiting bacterial protein synthesis, and novel resistance mechanisms
Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects
Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression
Drug repurposing
Quantifying Dynamic Phenotypic Heterogeneity in Resistant Escherichia coli under Translation‐Inhibiting Antibiotics
Drug repurposing in cardiology